Viking Therapeutics, Inc. (VKTX): 10-Q filed Apr 30, 2026

Form type

10-Q

Filing date

Apr 30, 2026

Accession number

0001193125-26-193315

Filer

Viking Therapeutics, Inc. (CIK 1607678)